Two classes of antidepressant account for most first-line prescriptions. The names look similar and sit one letter apart, which does nothing to clarify the difference. The distinction is real and it affects which one gets chosen. Here is what separates them in practice.
The Basic Difference
SSRI stands for selective serotonin reuptake inhibitor. These medications increase the availability of serotonin in the brain by slowing how quickly it is reabsorbed. SNRI stands for serotonin and norepinephrine reuptake inhibitor. These do the same thing with serotonin and act on norepinephrine as well.
Norepinephrine is involved in alertness, energy, and attention, along with how the body processes pain signals. That second neurotransmitter is the whole difference between the classes.
The Medications in Each Group
The SSRIs include fluoxetine, sertraline, escitalopram, citalopram, paroxetine, and fluvoxamine. All have been available for decades and all are available as generics. The SNRIs include venlafaxine, desvenlafaxine, duloxetine, and levomilnacipran. Most are also available generically, though fewer options exist overall.
Within each class the medications are not interchangeable. Two SSRIs can produce different results in the same person, which is why switching within a class is a reasonable step rather than a pointless one.
Which Gets Tried First
SSRIs are usually the starting point for depression and for most anxiety disorders. They have the longest track record, the widest evidence base, and generally milder side effects.
SNRIs are more often used second, after an SSRI has not worked well enough. They are also chosen first in specific situations.
Pain is the clearest of those situations. Duloxetine is approved for several pain conditions, including diabetic nerve pain and fibromyalgia, which makes it a reasonable single choice when depression and chronic pain occur together. Fatigue and low motivation sometimes point toward an SNRI as well, since the norepinephrine effect can help with energy.
How Side Effects Compare
Both classes share a common set of early side effects. Nausea, headache, disturbed sleep, and a period of increased restlessness are typical in the first week or two, and most ease as the body adjusts. Sexual side effects occur with both classes and are among the most common reasons people stop taking either. These tend not to resolve on their own, so they are worth raising rather than tolerating.
SNRIs carry some effects that SSRIs generally do not. Venlafaxine can raise blood pressure at higher doses, which means monitoring is part of treatment. Sweating and a faster heart rate are also more common.
SSRIs are more associated with weight changes over longer periods and, for some people, a sense of emotional flatness.
Neither class is free of side effects, and the comparison is about which profile suits a particular person.
Stopping & Discontinuation Effects
This is a practical difference worth knowing before starting either.
Both classes can produce discontinuation symptoms when stopped abruptly. These include dizziness, flu-like feelings, irritability, and brief electrical sensations people often describe as brain zaps.
Medications with a short half-life tend to produce this more noticeably. Venlafaxine and paroxetine are the two most associated with it, and missing even a single dose of venlafaxine can be felt.
Fluoxetine sits at the other end. Its long half-life means it tapers itself to some degree, and discontinuation effects are generally milder.
Neither class should be stopped without a plan. Tapering gradually under supervision avoids most of this.
How Long Each Takes to Work
The timelines are similar across both classes. Some effects on sleep and appetite appear within a week or two, while the full benefit generally takes four to six weeks. Side effects arrive first and benefit arrives later, which is the pattern that makes the early period discouraging. Anyone judging either class during week two is judging it on the worst sample.
Doses usually start low and increase gradually. The first prescription is often below the level expected to work, which is a common reason a medication gets written off before it is properly tested.
What Drives the Choice
The decision rarely comes down to the class itself. It depends on specifics that come out of an evaluation.
Your other medical conditions matter. Chronic pain points toward duloxetine, while uncontrolled high blood pressure counts against venlafaxine. Your previous responses matter more than almost anything. A medication that partly worked tells a psychiatrist something, and so does one that caused a particular side effect.
Family history carries weight too, since response to a specific antidepressant sometimes runs in families. Other medications you take factor in, as do cost, dosing frequency, and how you feel about the known side effect profiles.
If the First One Does Not Work
Roughly half of people do not get an adequate response from their first antidepressant, which is more common than most patients are told. That result narrows the options rather than ending them. Switching within the same class is reasonable, as is switching across classes, and so is increasing the dose when there has been partial improvement.
Adding a second medication is also standard practice rather than a last resort. Which direction fits depends on what the first attempt showed. The main thing to avoid is concluding that antidepressants do not work for you after one incomplete trial.
A Note on Safety
Both classes carry a warning about increased suicidal thinking in people under 25, particularly during the first weeks and after dose changes. This is a reason for closer monitoring early rather than a reason to avoid treatment.
Anyone experiencing new or worsening thoughts of self-harm after starting either should contact their prescriber promptly rather than waiting. In the United States, calling or texting 988 reaches the Suicide and Crisis Lifeline at any hour.